益生菌在减少呼吸机相关肺炎方面的潜力:基于文献的分析
Tao-An Chen1, Ya-Ting Chuang2, Szu-Chi Pai1
1Division of Respiratory Therapy, Department of Chest Medicine, Show Chwan Memorial Hospital, Changhua 500, Taiwan.
Microorganisms
|April 26, 2025
概括
益生菌可能会略微降低呼吸机相关肺炎 (VAP) 风险,但目前的证据有限. 需要进一步的大规模试验来确认它们在重症监护病房 (ICU) 的有效性和成本效益.
科学领域:
- 关键护理医学 关键护理医学
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 呼吸机相关肺炎 (VAP) 是一种严重的ICU并发症,患病率和死亡率高.
- 益生菌调节肠道微生物群,通过抑制病原体和增强免疫力,潜在地减少VAP.
- 现有的关于益生菌用于预防VAP的研究显示出混合的结果.
研究的目的:
- 评估益生菌和共生菌在预防VAP方面的疗效.
- 评估特定益生菌菌株对VAP发病率的影响.
- 审查益生菌在ICU使用的证据质量和成本效益.
主要方法:
- 随机对照试验 (RCT) 的系统审查和元分析.
- 对研究研究特定益生菌菌株的分析,例如*Lactobacillus rhamnosus* GG和*Bifidobacterium breve*.
- 检查有关益生菌干预措施的经济评估.
主要成果:
- 一些RCT表明,使用特定菌株可能降低VAP风险.
- 分析表明,可能有28-38%的相对风险降低,但证据质量不佳.
- 方法上的局限性和研究的异质性会影响研究结果的可靠性.
- 经济分析引发了有关成本效益的问题.
结论:
- 益生菌在VAP预防方面显示出潜在的,但不是最终的好处.
- 目前的证据质量不足以推益生菌作为主要的VAP策略.
- 更大,高质量的多中心RCT是必要的,以确定最佳使用和确认疗效.
相关概念视频
01:30Pneumonia V: Nursing management and Prevention
1.6K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.6K
01:30Pneumonia I: Introduction
184
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
184
01:23Mechanical Ventilation III: Noninvasive Ventilation
55
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
55
01:28Pneumonia IV: Management
264
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
264
01:30Pneumonia III: Complications and Assessment
117
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
117
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K